Journal reading

Treating hepatitis C - what’s new?

Chronic hepatitis C infection causes cirrhosis, liver failure and hepatocellular carcinoma, and is the most common indication for liver transplantation. Hepatitis C is curable and complications can be prevented.

Alex J Thompson and Jacinta A Holmes, Aust Prescr 2015;38:191-7

  • Cost: free

START NOW
Treating hepatitis C - what’s new?
 

Accreditation

This activity should take approximately 1 hour to complete. It can be included in a pharmacist’s CPD Plan for either one Group 1 credit or, on successful completion of the assessment activity, two Group 2 credits. Pharmacists should self-record this activity for CPD purposes.

Pharmacy Competency Standards

  • 1.4 Manage quality and safety
  • 4.2 Consider the appropriateness of prescribed medicines
  • 7.1 Contribute to therapeutic decision making
  • 7.2 Provide ongoing medication management
 

About

This activity has been designed to take around 1 hour to complete - this is based on reading the article from an issue of Australian Prescriber and completing a quiz. You will be provided with immediate feedback on your answers and a certificate of completion will be available for you to download for self-reporting purposes.

 

Learning objectives

  1. Recognise who may have a higher risk of hepatitis C.
  2. Recognise and differentiate drug regimens for hepatitis C.
  3. Identify potential adverse effects, contraindications and drug interactions of hepatitis C drugs.
START NOW